QJM-AN INTERNATIONAL JOURNAL OF MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2019-06-05 574011435_53824356

一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。

169 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2022-03-19 1de6caf9m07(暂无匿称)

发文量控制的非常严格，要求比较高，好杂志

33 0

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2021-12-28 Mia

怎么撰写引言？区别于讨论？

42 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

引言和讨论如何写的不重复？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2018-05-25 qiangq

审稿速度:1.0 | 投稿命中率:25.0
经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。

292 0

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-07-18 chenyuming

3分边缘，希望能维持稳定，略有上升也不错。

381 0

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-07-18 chenyuming

3分边缘，希望能维持稳定，略有上升也不错。

322 0

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-04-06 我叫谢跳跳

审稿速度:1.0 | 投稿命中率:25.0
经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了

357 0

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-03-31 proflin

审稿速度:1.0 | 投稿命中率:25.0
经验分享：審查快速

1-2個月

344 0

[GetPortalCommentsPageByObjectIdResponse(id=571916, encodeId=215e5e19166a, content=一个妇产科领域的文章，我在20个小时被秒拒了，什么理由都没有。我本来想给主编发个邮件问问咋回事儿，后来一想，这种秒拒即使知道了也意义不大，就改投另一个妇产科领域的杂志了，还在等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5f2252783, createdName=574011435_53824356, createdTime=Wed Jun 05 16:37:00 CST 2019, time=2019-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203966, encodeId=b6ff120396621, content=发文量控制的非常严格，要求比较高，好杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766e1695923, createdName=1de6caf9m07(暂无匿称), createdTime=Sat Mar 19 09:13:44 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099695, encodeId=534a10996952b, content=怎么撰写引言？区别于讨论？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099696, encodeId=c5291099696b0, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556443, encodeId=fb2e55644386, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：非常幸运，第一往篇文章发表时，是在第七天时immediately accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:35:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539456, encodeId=e9cf53945600, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539436, encodeId=d10d53943645, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535189, encodeId=a07d535189fe, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：研究方向：临床心血管病相关。1个月直接拒了。要求很严。后来我文章没怎么改投medicine去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8051638727, createdName=我叫谢跳跳, createdTime=Thu Apr 06 10:00:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534947, encodeId=5fef53494e90, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：審查快速 1-2個月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c82044732, createdName=proflin, createdTime=Fri Mar 31 19:19:00 CST 2017, time=2017-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533964, encodeId=43db53396468, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：投了一篇CASE，1周后秒拒 “Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=360014297, createdName=jqy119, createdTime=Fri Mar 10 15:14:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-03-10 jqy119

审稿速度:1.0 | 投稿命中率:5.0
经验分享：投了一篇CASE，1周后秒拒
“Unfortunately we will not be able to accept your recently submitted manuscript for publication. Please be advised there is a highly competitive number of articles submitted to the journal and acceptance is less than 5%.”

309 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务